Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Amenamevir by Ugi-4CR

Li X., Zarganes-Tzitzikas T., Kurpiewska K., Dömling A.

We report a concise, convenient and sustainable multicomponent reaction synthesis of the approved anti-herpes zoster drug, Amenamevir.

More information Original publication

DOI

10.1039/d2gc04869h

Type

Journal article

Publisher

Royal Society of Chemistry (RSC)

Publication Date

2023-01-01T00:00:00+00:00

Volume

25

Pages

1322 - 1325

Total pages

3